Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Contributes 'Omics Tools to Denver Research Hospital for Systems Bio Training Courses

NEW YORK (GenomeWeb News) — Agilent Technologies and the National Jewish Medical and Research Center will provide educational training focused on systems biology applications, Agilent said.
The training programs, which will be open to the public, include e-seminars, classroom courses, and hands-on instruction on life-science hardware, the company said.
Agilent will provide a 6410 triple quadrupole liquid chromatography/mass spectrometer; a 6510 quadrupole time-of-flight LC/MS with HPLC chip technology; a 6210 TOF LC/MS with electrospray ionization; a 6340 ion trap LC/MS with HPLC chip technology; several 1200 Series HPLCs, including the Rapid Resolution LC system; a 2100 Bioanalyzer; a DNA microarray scanner with analysis software; GeneSpring GX and MS software for statistical analysis of array and mass spectrometry data; SpectrumMill software for analysis of peptides and proteins; and proteomics LC columns, including macroporous reverse phase columns for separating intact proteins and MARS immunodepletion columns for isolation of plasma proteins.
"Agilent's integrated collection of mass spectrometers, DNA microarrays, and informatics software allows us to teach coherent, comprehensive 'omics' techniques in our lab," said Nichole Reisdorph, assistant professor of immunology and director of the National Jewish mass spectrometry facility. Reisdorph will lead the training programs, Agilent said.
Reisdorph said the collaboration will allow NJMRC students to study systems biology and the “amazing answers that are now available via modern tools and techniques” without having to “combine disjointed platforms from many vendors.”
The courses include the new "Hands-on Metabolomics and Proteomics Workshop" to be held Aug. 27-31, as well as database-searching and clinical-proteomics programs.
Information about the center's curriculum of novice, intermediate, and advanced courses is available here.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.